← back to search

Henit Yanai

Icahn School of Medicine at Mount Sinai · IL
Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Autoimmune and Inflammatory Disorders, and Gastrointestinal Bleeding Diagnosis and Treatment.
h-index
37
citations
4,891
works
310
NIH funding
primary concept
Medicine
email

Recent publications

ECCO consensus on management of inflammatory bowel disease in low- and middle-income countries.
2026cited by 3position: contributordoi
Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study.
2026cited by 1position: contributordoi
Precision nutrition for the prevention and management of inflammatory bowel disease
Nature Reviews Gastroenterology & Hepatology 2026cited by 0position: contributordoi
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1
Journal of Crohn s and Colitis 2025cited by 60position: middledoi
European Crohn’s and Colitis Organisation consensus on dietary management of inflammatory bowel disease
Journal of Crohn s and Colitis 2025cited by 33position: middledoi
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2
Journal of Crohn s and Colitis 2025cited by 25position: firstdoi
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1.
2025cited by 22position: contributordoi
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2.
2025cited by 17position: contributordoi
European Crohn's and Colitis Organisation consensus on dietary management of inflammatory bowel disease.
2025cited by 13position: contributordoi
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN.
2025cited by 6position: contributordoi
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.
2025cited by 5position: contributordoi
The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children.
2025cited by 3position: contributordoi
Discordant Effects of Janus Kinase Inhibition Ex Vivo on Inflammatory Responses in Colonic Compared to Ileal Mucosa.
2025cited by 3position: contributordoi
Factors Associated With Biologic Therapy After Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis.
2025cited by 2position: contributordoi
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey.
2025cited by 2position: contributordoi
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection.
2025cited by 2position: contributordoi
Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study
Inflammatory Bowel Diseases 2025cited by 1position: firstdoi
Letter: Change in Bowel Urgency in Active Ulcerative Colitis Patients Treated with Curcumin-QingDai (CurQD): A Post Hoc Analysis of a Randomized Placebo-Controlled Trial.
2025cited by 1position: contributordoi
Industrial Bread Composition: Potential Implications for Patients with Inflammatory Bowel Disease.
2025cited by 1position: contributordoi
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY survey.
2025cited by 1position: contributordoi
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study.
2025cited by 1position: contributordoi
Microbial Shift Over 1 Year Among Patients With Newly Diagnosed Crohn's Disease Reflects Clinical Trajectory and Exposure to Biologic Treatment: A Prospective Real-World Inception Cohort.
2025cited by 0position: contributordoi
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
Journal of Crohn s and Colitis 2024cited by 289position: middledoi
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
2024cited by 190position: contributordoi
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
Journal of Crohn s and Colitis 2024cited by 130position: middledoi
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
2024cited by 82position: contributordoi
The Crohn's Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions.
2024cited by 35position: contributordoi
Predictors of Complicated Disease Course in Adults and Children With Crohn’s Disease: A Nationwide Study from the epi-IIRN
Inflammatory Bowel Diseases 2024cited by 8position: middledoi
Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis
Digestive and Liver Disease 2024cited by 7position: middledoi
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN
Inflammatory Bowel Diseases 2024cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Iris Dotan · Tel Aviv University66 papers (2017–2025) · 32 papers (2021–2026)Nitsan Maharshak · University of Haifa16 papers (2019–2024) · 12 papers (2021–2025)Jacob E. Ollech · Tel Aviv University10 papers (2020–2024)Uri Kopylov · Tel Aviv University9 papers (2017–2024)Irit Avni‐Biron · Tel Aviv University9 papers (2017–2024)Uri Kopylov · Tel Aviv University8 papers (2019–2025)Eran Zittan · University of Haifa8 papers (2017–2024)Yehuda Chowers · Rambam Health Care Campus8 papers (2017–2021)Dan Turner · Oxford Nanopore Technologies (United Kingdom)7 papers (2019–2024)Lihi Godny · Unité de Nutrition Humaine7 papers (2021–2025)Revital Kariv · Hebrew University of Jerusalem7 papers (2021–2024)Ariella Bar‐Gil Shitrit · Shaare Zedek Medical Center7 papers (2017–2023) · 7 papers (2021–2024)Eran Matz · Atrium Health Wake Forest Baptist7 papers (2021–2024)Ohad Atia · Hebrew University of Jerusalem7 papers (2021–2024)Yiska Loewenberg-Weisband · Hebrew University of Jerusalem6 papers (2021–2024) · 6 papers (2021–2024)Alessandro Armuzzi · Fondazione Humanitas per la Ricerca6 papers (2021–2025)